As of close of business last night, scPharmaceuticals Inc’s stock clocked out at $5.25, up 4.58% from its previous closing price of $5.02. In other words, the price has increased by $+0.23 from its previous closing price. On the day, 834409 shares were traded. SCPH stock price reached its highest trading level at $5.26 during the session, while it also had its lowest trading level at $4.96.
To gain a deeper understanding of SCPH’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.88 and its Current Ratio is at 9.53. In the meantime, Its Debt-to-Equity ratio is 0.81 whereas as Long-Term Debt/Eq ratio is at 0.80.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on September 07, 2023, initiated with a Buy rating and assigned the stock a target price of $20.
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 25 when ORBIMED ADVISORS LLC bought 762,380 shares for $5.25 per share. The transaction valued at 4,002,495 led to the insider holds 5,328,328 shares of the business.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SCPH now has a Market Capitalization of 188.27M and an Enterprise Value of 137.88M. For the stock, the TTM Price-to-Sale (P/S) ratio is 25.10 while its Price-to-Book (P/B) ratio in mrq is 3.83. Its current Enterprise Value per Revenue stands at 18.39 whereas that against EBITDA is -3.31.
Stock Price History:
Over the past 52 weeks, SCPH has reached a high of $12.75, while it has fallen to a 52-week low of $4.63. The 50-Day Moving Average of the stock is 6.12, while the 200-Day Moving Average is calculated to be 8.29.
It appears that SCPH traded 232.69K shares on average per day over the past three months and 457.76k shares per day over the past ten days. A total of 34.26M shares are outstanding, with a floating share count of 23.55M. Insiders hold about 34.32% of the company’s shares, while institutions hold 64.75% stake in the company. Shares short for SCPH as of Oct 30, 2023 were 6.53M with a Short Ratio of 6.53M, compared to 6.83M on Sep 28, 2023. Therefore, it implies a Short% of Shares Outstanding of 18.21% and a Short% of Float of 21.70%.
As of right now, 6 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.42 for the current quarter, with a high estimate of -$0.32 and a low estimate of -$0.53, while EPS last year was -$0.3. The consensus estimate for the next quarter is -$0.36, with high estimates of -$0.32 and low estimates of -$0.39.
Analysts are recommending an EPS of between -$1.39 and -$1.6 for the fiscal current year, implying an average EPS of -$1.49. EPS for the following year is -$1.19, with 6 analysts recommending between -$0.93 and -$1.43.
Based on 6 analysts’ estimates, the company’s revenue will be $38.38M in the next fiscal year. The high estimate is $42.2M and the low estimate is $33.01M. The average revenue growth estimate for next year is up 199.40% from the average revenue estimate for this year.